Discover 1,973 paid clinical trials in Fort Lauderdale, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,973
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Get alerts for new trials in your area by subscribing now
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Pembroke Pines FL, Hattiesburg MS, Charlottesville VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05947851
Phase3, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Pembroke Pines FL, Miami FL, Tampa FL, Gainesville FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Pembroke Pines FL, Weston FL, Charlotte NC,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase3, Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
for
Endometrial Cancer, Malignant Solid Tumour
Location: Miami Beach FL, Miami FL, West Palm Beach FL,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT07044336
Phase3, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Miami Beach FL, West Palm Beach FL, Orlando FL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Miami Beach FL, West Palm Beach FL, Fort Myers FL,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
for
Lysosomal Acid Lipase Deficiency,
Location: Miramar FL, Orlando FL, Atlanta GA, Jackson MS,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT01633489
Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment